ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,668Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 890

$861K Total Retail Price of All Prescriptions

Rank: 79 out of 890

696 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 696 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

18% of this provider’s 696 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 13,465 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 759 661 1 2
SIMVASTATIN 614 492 2 5
LISINOPRIL 422 350 3 4
METOPROLOL TARTRATE 414 345 4 15
HYDROCODONE-ACETAMINOPHEN 407 280 S3 5 3
AMLODIPINE BESYLATE 362 307 6 1
FUROSEMIDE 356 284 7 7
METFORMIN HCL 342 273 8 6
ATORVASTATIN CALCIUM 341 269 9 13
POTASSIUM CHLORIDE 316 266 10 11
PANTOPRAZOLE SODIUM 304 272 11 34
OMEPRAZOLE 280 185 12 8
BENAZEPRIL HCL 268 211 13 44
ZOLPIDEM TARTRATE 253 222 14 19
METOPROLOL SUCCINATE 244 207 15 17
PRAVASTATIN SODIUM 244 216 15 10
HYDROCHLOROTHIAZIDE 241 232 17 9
CITALOPRAM HBR 229 179 18 20
WARFARIN SODIUM 226 220 19 24
METFORMIN HCL ER 215 193 20 54
FENOFIBRATE 212 128 21 74
LOSARTAN POTASSIUM 199 129 22 29
CLOPIDOGREL 198 164 23 28
ATENOLOL 184 177 24 23
ALLOPURINOL 180 130 25 31
PREDNISONE 169 124 26 47
PLAVIX 161 140 27 42
TAMSULOSIN HCL 161 148 27 32
TRAMADOL HCL 156 124 29 16
PROAIR HFA 154 106 30 55
CRESTOR 151 125 31 25
GABAPENTIN 148 119 32 12
ALENDRONATE SODIUM 144 131 33 38
DONEPEZIL HCL 136 136 34 30
NEXIUM 136 101 34 14
DIOVAN 127 112 36 33
FLUTICASONE PROPIONATE 127 96 36 39
RANITIDINE HCL 121 101 38 49
ENALAPRIL MALEATE 119 113 39 56
DOXYCYCLINE HYCLATE 117 80 40 89
GLIMEPIRIDE 113 89 41 27
LEVOFLOXACIN 113 93 41 107
ISOSORBIDE MONONITRATE ER 110 92 43 60
LOVASTATIN 109 104 44 46
MELOXICAM 108 89 45 18
CARVEDILOL 101 70 46 22
SERTRALINE HCL 97 82 47 26
CEFUROXIME 96 86 48 168
GLYBURIDE 95 62 R 49 83
KLOR-CON 10 85 83 50 189
DIGOXIN 82 82 51 65
TIZANIDINE HCL 82 51 51 106
CLONIDINE HCL 81 70 53 35
AZITHROMYCIN 78 59 54 37
VERAPAMIL ER 76 67 55 87
VENLAFAXINE HCL ER 75 56 56 114
SPIRIVA 74 68 57 66
DILTIAZEM 24HR CD 74 69 57 156
DOXAZOSIN MESYLATE 73 67 59 70
FINASTERIDE 73 69 59 108
DIOVAN HCT 70 59 61 48
AMITRIPTYLINE HCL 69 43 R 62 43
TRAZODONE HCL 69 41 62 40
ADVAIR DISKUS 69 67 62 52
KLOR-CON M20 68 59 65 72
AMLODIPINE BESYLATE-BENAZEPRIL 66 42 66 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 43 67 21
CYMBALTA 64 41 68 45
LANSOPRAZOLE 62 62 69 171
ALPRAZOLAM 62 57 69 95
VENLAFAXINE HCL 61 50 71 287
TRIAMTERENE-HCTZ 59 40 72 61
PEN NEEDLE 58 25 73 135
BUPROPION HCL SR 58 24 73 216
LANTUS SOLOSTAR 58 43 73 102
ZOSTAVAX 57 55 76 233
RAMIPRIL 57 44 76 80
LANTUS 56 32 78 50
NAMENDA 56 56 78 36
INSULIN SYRINGE 56 34 78 99
OXYCODONE-ACETAMINOPHEN 56 29 S2 78 250
SYNTHROID 55 32 82 53
LIPITOR 54 33 83 77
SYMBICORT 51 43 84 174
ESTRADIOL 50 35 R 85 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.